* Registration is FREE * Note this session will be presented using VOIP. A phone number will not be available * 1 FREE CPEU Credit will be earned for live attendance.
Webinar will be recorded and posted to the AIND website for later viewing. SLIDES and RECORDING will be sent to ALL REGISTRANTS,
Session Summary : Each year 10 million post-menopausal American women are diagnosed with osteoporosis. Half of all post-menopausal women have an osteoporosis-related bone fracture during their lives. With millions of baby-boomer women going through peri-menopausal or post-menopausal, those statistics are expected to increase significantly. To preempt this bone loss, some post-menopausal women are prescribed hormone replacement, most are encouraged to consume a diet rich in micro-nutrients, and exercise regularly. However, 70% of the variability in bone mass in humans is associated with multiple genes across different biological systems. Using case histories, this presentation highlights how genotype impacts risk for osteopenia/osteoporosis by identifying polygenic single nucleotide polymorphisms (SNPs) associated with reduced bone mass, how nutrigenomic interventions can mitigate their effects, and how assessing specific biomarkers can lead to better health outcomes for this at-risk population.
This presentation will introduce evidence-based information connecting genomics and bone health and use case histories to educate attendees about the genes involved in bone formation and bone degradation, how gene variants involved in osteogenesis, nutrient utilization and inflammation can alter bone mass, how personalized nutrigenomic and lifestyle interventions based on a woman's DNA map can prevent bone loss or reverse it in women diagnosed with osteopenia or osteoporosis. RDNs will be provided with novel intervention strategies for this cutting-edge approach to bone health.
Presenter: Susan Allen-Evenson, RDN, LDN, CCN Highly recognized Functional Nutrition expert, Susan Allen-Evenson incorporates an overall focus on the Integrative and Functional Medicine approach in her work as a speaker, mentor, author and nutrition consultant. In addition to her own private practice, she was involved in one of the first nationally-based Integrative Medicine clinics and consulted for the development of a major hospital system's Integrative Medicine Center. Ms. Allen has held board appointments with The International and American Association of Clinical Nutritionists, the Academy of Nutrition and Dietetics’ sub-specialty group: Dietitian’s in Integrative and Functional Medicine (DIFM), and on the Nutrition Board of the Institute for Functional Medicine (IFM). In her more than two decades of practice, Susan has recognized the growing divide between traditional dietetics training and the emerging trends in Integrative and Functional Medicine. With her passion for educating and understanding many dietitians are missing a key opportunity; she launched a unique national mentoring initiative to provide training for registered dietitians to learn this specialty. Considered an authority, she has appeared on numerous radio and television programs, has been quoted extensively in the press, and is also a published author. She was Chief Nutritional Consultant for the Reader’s Digest book; Food Cures: Breakthrough Nutritional Prescriptions for Everything from Colds to Cancer and she was a contributing author to the first college textbook of its kind, Integrating Therapeutic and Complementary Nutrition, CRC Press 2007. Ms. Allen has also authored a chapter in AAPI's Nutrition Guide To Optimal Health: Using Principles of Functional Medicine and Nutritional Genomics - Part 2. NextLevelFunctionalNutrition.com
Objectives : 1) Describe the function of genes involved in bone formation/degradation and explain how gene SNPs associated with osteogenesis impact biochemical and metabolic pathways leading to a loss of bone mass. 2) Recognize how gene variants in bone formation and bone degradation, nutrient utilization, inflammation and exercise can alter bone mass and lead to osteopenia or osteoporosis. 3) Utilize genomic testing to recommend and bio-markers to evaluate the efficacy of personalized, evidenced-based nutrigenomic interventions in the prevention or treatment of osteopenia or osteoporosis